InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Meek David D., Director. Officer active across 4 companies, notably Mirati Therapeutics, Inc.. In total, 15 disclosures have been recorded. Split: 0 buy · 5 sells. Total volume traded: €178k. History available since 14 January 2022. The latest transaction was filed on 20 June 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Meek David D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
2,112 shares@ US$14.45100.0% of flowOrdinary SharesSEC:0000904454-25-000328:0
7,970 shares0Ordinary SharesSEC:0000904454-25-000305:0
8,080 shares0Ordinary SharesSEC:0000904454-24-000403:0
2,229 shares@ US$5.1239.5% of flowOrdinary SharesSEC:0000904454-24-000373:0
8,700 shares0Ordinary SharesSEC:0000904454-23-000398:0
389 shares@ US$19.7127.0% of flowOrdinary SharesSEC:0000899243-23-006571:0
89,379 shares0Common StockSEC:0001214659-23-001042:0
3,179 shares@ US$42.3764100.0% of flowCommon StockSEC:0001214659-23-000810:0
35,425 shares0Common StockSEC:0001214659-22-015198:0
22,000 shares@ US$2.20100.0% of flowCommon StockSEC:0001104659-22-078797:0
9,080 shares0Ordinary SharesSEC:0000904454-22-000352:0
602 shares@ US$16.700.0006% mcap100.0% of flowOrdinary SharesSEC:0000904454-22-000215:0
1,534 shares0Ordinary SharesSEC:0000904454-22-000193:0
27,500 shares0Common StockSEC:0001104659-22-005415:0
34,057 shares0Common StockSEC:0001214659-22-000844:0
15 of 15 declarations
About Meek David D.
David D. Meek is Chief Executive Officer and Director at Mirati Therapeutics, Inc., Entasis Therapeutics Holdings Inc., and uniQure N.V. He leads these companies in developing innovative therapies for serious diseases. David uses his expertise to guide the strategy and growth of these organizations.
